Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innova CaptabNSE:INNOVACAP -0.65%46 OCF Yield % is 2.06 as of Jul. 15, 2026, which is 20% below its 10-year median of 2.58. GuruFocus rates NSE:INNOVACAP with a GF Score™ of 46/100. The stock has 6 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Innova Captab ranks worse than 58.09% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Innova Captab's OCF Yield % or its related term are showing as below:
NSE:INNOVACAP'
s OCF Yield % Range Over the Past 10 Years
Min: 0.67 Med: 2.58 Max: 3.03
Current: 2.06
During the past 8 years, the highest OCF Yield % of Innova Captab was 3.03%. The lowest was 0.67%. And the median was 2.58%.
NSE:INNOVACAP's OCF Yield % is ranked worse than 58.09% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.48
vs NSE:INNOVACAP: 2.06
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Innova Captab OCF Yield % Related Terms
Innova Captab OCF Yield % Historical Data
* Premium members only.
The historical data trend for Innova Captab's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INNOVACAP vs ZTS, UTHR: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innova Captab OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Innova Captab's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Innova Captab's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innova Captab (NSE:INNOVACAP) has a OCF Yield % of 2.06 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Innova Captab and its competitors. This is 20% below median its historical median of 2.58. Over the past decade, Innova Captab's OCF Yield % has ranged from 0.67 to 3.03. According to the industry distribution chart, Innova Captab ranks #585 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 58.1%.
Is Innova Captab's OCF Yield % too high?
Innova Captab's current OCF Yield % of 2.06 is 20% below median its 10-year median of 2.58. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 3.03. The Drug Manufacturers industry median OCF Yield % is 3.48. Innova Captab's value of 2.06 is 40.8% below this industry median. Based on the distribution chart, Innova Captab ranks #585 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Innova Captab ranks #585 out of 1007 companies for OCF Yield %. This places Innova Captab in the lower half of its industry. The industry median OCF Yield % is 3.48. Innova Captab's value of 2.06 is 40.8% below this benchmark. Historically, Innova Captab's own OCF Yield % has ranged from 0.67 to 3.03 over the past decade. While the company's 10-year median is 2.58 vs. the industry median of 3.48, Innova Captab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.48, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innova Captab's current OCF Yield % of 2.06 is 40.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Innova Captab and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innova Captab's current OCF Yield % is 2.06, which is 20% below median its own 10-year median of 2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (NSE:INNOVACAP) has a current OCF Yield % of 2.06. The current OCF Yield % is 2.06, which is 20% below median its 10-year median of 2.58 and 40.8% below the Drug Manufacturers industry median of 3.48. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Innova Captab (NSE:INNOVACAP), the current OCF Yield % is 2.06 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score
Get the complete analysis for NSE:INNOVACAP
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INNOVACAP has been successfully added to your 
